1-3 of 3
Keywords: intestinal microbiota
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

PE (0:0/14:0), an endogenous metabolite of the gut microbiota, exerts protective effects against sepsis-induced intestinal injury by modulating the AHR/CYP1A1 pathway

Available to Purchase
Wang Ze Tian, Qi Yue, Wang Fei, Peng Zi Yao, Rui Qin Han, Jianguo Tang
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (22): 1753–1769.
https://doi.org/10.1042/CS20230704
Published: 22 November 2023
... 2023 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2023 Aryl hydrocarbon receptor Intestinal barrier function Intestinal microbiota PE(0:0/14:0) Sepsis Sepsis is a severe medical condition that is known to have high rates of mortality...
View articletitled, PE (0:0/14:0), an endogenous metabolite of the gut microbiota, exerts protective effects against sepsis-induced intestinal injury by modulating the AHR/CYP1A1 pathway
Open the PDF for PE (0:0/14:0), an endogenous metabolite of the gut microbiota, exerts protective effects against sepsis-induced intestinal injury by modulating the AHR/CYP1A1 pathway in another window
Articles

Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease

Available to Purchase
Siqi Wang, Dan Lv, Shuanghong Jiang, Jianpin Jiang, Min Liang, Fanfan Hou, Ye Chen
Journal: Clinical Science
Clin Sci (Lond) (2019) 133 (17): 1857–1870.
https://doi.org/10.1042/CS20190171
Published: 10 September 2019
... fibrosis, and persistent intestinal flora disturbance are common in CKD. Short-chain fatty acids (SCFAs), produced by the intestinal microbiota, have been previously reported to ameliorate kidney injury; however, the specific concentrations and types that are required to improve renal function remain...
View articletitled, Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease
Open the PDF for Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease in another window
Includes: Supplementary data
Articles

The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease

Available to Purchase
Katharine G. Harris, Eugene B. Chang
Journal: Clinical Science
Clin Sci (Lond) (2018) 132 (18): 2013–2028.
https://doi.org/10.1042/CS20171110
Published: 19 September 2018
...Katharine G. Harris; Eugene B. Chang Inflammatory bowel diseases (IBD) are a group of chronic diseases of increasing worldwide prevalence characterized by gastrointestinal (GI) inflammation leading to debilitating symptoms and complications. The contribution of the intestinal microbiota...
View articletitled, The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease
Open the PDF for The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease in another window